The cholinergic system and inflammation: Common pathways in delirium pathophysiology

Journal of the American Geriatrics Society

Volumn 60, Issue 4, 2012, Pages 669-675

  Cerejeira, Joaquim Manuel Soares ^a,b   Nogueira, Vasco ^a,b   Luís, Pedro ^a   Vaz Serra, Adriano ^b   Mukaetova Ladinska, Elizabeta B ^c  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

C reactive protein; Cholinesterases; Cytokines; Delirium; Inflammation

Indexed keywords

ACETYLCHOLINESTERASE; C REACTIVE PROTEIN; CHOLINESTERASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTHROPLASTY; ARTICLE; CHOLINERGIC SYSTEM; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DELIRIUM; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNE SYSTEM; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLINESTERASES; CYTOKINES; DELIRIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 84859817991     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03883.x     Document Type: Article

References (36)

1. Cerejeira J, Mukaetova-Ladinska EB. A clinical update on delirium: From early recognition to effective management. Nurs Res Pract 2011;2011:875196
2. Cerejeira J, Firmino H, Vaz-Serra A et al. The neuroinflammatory hypothesis of delirium. Acta Neuropathol 2010;119:737-754.
3. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009;9:418-428.
4. Macdonald A, Adamis D, Treloar A et al. C-reactive protein levels predict the incidence of delirium and recovery from it. Age Ageing 2007;36:222-225. (Pubitemid 46455405)
5. White S, Eeles E, O'Mahony S et al. Delirium and C-reactive protein. Age Ageing 2008;37:123-124.
6. Burkhart CS, Dell-Kuster S, Gamberini M et al. Modifiable and nonmodifiable risk factors for postoperative delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2010;24:555-559.
7. Rudolph JL, Ramlawi B, Levkoff SE et al. Inflammation and delirium after cardiac surgery. J Am Geriatr Soc 2006;54(4S):S201-S202.
8. de Rooij SE, van Munster BC, Korevaar JC et al. Cytokines and acute phase response in delirium. J Psychosom Res 2007;62:521-525. (Pubitemid 46635470)
9. Adamis D, Treloar A, Martin FC et al. APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. Int J Geriatr Psychiatry 2007;22:688-694. (Pubitemid 47180383)
10. Adamis D, Lunn M, Martin FC et al. Cytokines and IGF-I in delirious and nondelirious acutely ill older medical inpatients. Age Ageing 2009;38:326-332.
11. Hudetz JA, Patterson KM, Iqbal Z et al. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2009;23:651-657.
12. van Munster BC, Korevaar JC, Zwinderman AH et al. Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 2008;56:1704-1709.
13. Lemstra AW, Kalisvaart KJ, Vreeswijk R et al. Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients. Int J Geriatr Psychiatry 2008;23:943-948.
14. Rudolph JL, Ramlawi B, Kuchel GA et al. Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci 2008;63A:184-189. (Pubitemid 351738450)
15. van Munster BC, Bisschop PH, Zwinderman AH et al. Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn 2010;74:18-23.
16. Holmes C, Cunningham C, Zotova E et al. Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 2011;77:212-218.
17. Beloosesky Y, Hendel D, Weiss A et al. Cytokines and C-reactive protein production in hip-fracture-operated elderly patients. J Gerontol A Biol Sci Med Sci 2007;62A:420-426. (Pubitemid 47065711)
18. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009;265:663-679.
19. Cerejeira J, Batista P, Nogueira V et al. Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients. Age Ageing 2011;40:621-626.
20. Carnahan RM, Lund BC, Perry PJ et al. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity. J Clin Pharmacol 2006;46:1481-1486. (Pubitemid 44704208)
21. Hshieh TT, Fong TG, Marcantonio ER et al. Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008;63A:764-772.
22. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000;127:117-126. (Pubitemid 30091254)
23. Kilic T, Ural D, Ural E et al. Relation between proinflammatory to antiinflammatory cytokine ratios and long-term prognosis in patients with non- ST elevation acute coronary syndrome. Heart 2006;92:1041-1046. (Pubitemid 44125212)
24. Rajappa M, Sen SK, Sharma A. Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in South Indians with coronary artery disease. Angiology 2009;60:419-426.
25. Kellum JA, Kong L, Fink MP et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007;167:1655-1663. (Pubitemid 47280347)
26. Gogos CA, Drosou E, Bassaris HP et al. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 2000;181:176-180. (Pubitemid 30049046)
27. O'Connor JC, McCusker RH, Strle K et al. Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology. Cell Immunol 2008;252:91-110.
28. Livolsi A, Niederhoffer N, Dali-Youcef N et al. Constitutive overexpression of muscarinic receptors leads to vagal hyperreactivity. PLoS ONE 2010;5:e15618. Erratum in: PLoS One 2011;6. doi: 10.1371/annotation/2747fb4d- de47-4e66-81f9-76b5f5ac4b90.
29. Pavlov VA, Parrish WR, Rosas-Ballina M et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic antiinflammatory pathway. Brain Behav Immun 2009;23:41-45.
30. Liu ZH, Ma YF, Wu JS et al. Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis. Chin Med J (Engl) 2010;123:1727-1730.
31. Nakahara T, Kawada T, Sugimachi M et al. Cholinesterase affects dynamic transduction properties from vagal stimulation to heart rate. Am J Physiol 1998;2:R541-R547.
32. Paes AM, Carniatto SR, Francisco FA et al. Acetylcholinesterase activity changes on visceral organs of VMH lesion-induced obese rats. Int J Neurosci 2006;116:1295-1302. (Pubitemid 44454435)
33. van Eijk MM, Roes KC, Honing ML et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010;376:1829-1837.
34. Fernandez-Cabezudo MJ, Lorke DE, Azimullah S et al. Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium. Immunology 2010;130:388-398.
35. Leng SX, McElhaney JE, Walston JD et al. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008;63A:879-884.
36. Giannoudis PV. Current concepts of the inflammatory response after major trauma: An update. Injury 2003;34:397-404. (Pubitemid 36593216)